Rob Cawthon 23 Jan 2016, 13:23

$GSK @Barry-Gardiner the dividends are high but you should take into account that the stock is very cyclical and in the decline since mid-2014 #hold

Barry Gardiner 22 Jan 2016, 22:22

$GSK GlaxoSmithKline’s 2016 dividends are expected at 5.9% - a nice number for a leading player in the industry #bullish

Stephen Dixon 17 Jun 2015, 08:25

$GSK heres is one more proof to the previous post - Glaxo is seeding basic research to make drug discovery more efficient. www.bloomberg.com/news/ar...elopment

Stephen Dixon 15 Jun 2015, 22:55

$GSK $AZN R&D is going out of fashion in the 21st century... less and less companies are willing to invest in real research #neutral

David Lyons 08 Jun 2015, 22:30

$GSK changed its strategy from being a pharma company like $AZN to being an FMCG producer like $ULVR / GSK has shifted its focus from R&D to distribution of over-the-counter drugs www.fool.co.uk/investing/...eca-plc/

Stephen Dixon 07 May 2015, 10:23

$GSK unveiled a surprise strategic U-turn as the group shelved plans to spin-off an HIV joint venture and axed a £4billion return of cash to shareholders. Chief exec. Sir Andrew Witty yesterday described the decision to refocus on cheaper vaccines and consumer healthcare as ‘quite a big strategic shift’. #buy www.thisismoney.co.uk/mon...ers.html

David Lyons 05 Apr 2015, 12:47

$GSK big brokers have opposite views on the Glaxosmithkline stock in their March and April reports. That tell me to stay away or at least #hold

Barclays Capital 1,840.00p Overweight
JP Morgan Cazenove 1,250.00p Underweight
Morgan Stanley 1,800.00p Overweight
Credit Suisse 1,440.00p Underperform
Jefferies International 1,550.00p Hold
Goldman Sachs 1,670.00p Buy